Marsh & McLennan Companies reported second quarter 2026 earnings and updated on its share repurchase program and automation initiatives with SS&C Blue Prism. The stock trades at a price-to-earnings ratio of 21.2 times, which is above the estimated fair P/E of 13.7 times and the US Insurance industry average of 12.1 times, yet a discounted cash flow model from Simply Wall St estimates a fair value of $283.79 per share, implying the stock is 37.8% undervalued at its current price of $176.40. The company generated $27.9 billion in revenue and $3.98 billion in net income, and its P/E sits at a modest discount to close peers trading at 23.5 times. The mixed valuation signals leave investors weighing whether the premium multiple will compress toward industry levels or if the cash-flow-based discount represents a buying opportunity.
Marsh & McLennan Companies, Inc.DCF model suggests 38% undervaluation, plus share repurchase program and earnings update.